HTA38 When and How Does RWE Impact HTA Outcomes in Oncology? A Qualitative Evaluation of Case Studies to Identify Drivers of RWE Acceptance Today and in the Future
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1498
https://www.valueinhealthjournal.com/article/S1098-3015(22)03703-2/fulltext
Title :
HTA38 When and How Does RWE Impact HTA Outcomes in Oncology? A Qualitative Evaluation of Case Studies to Identify Drivers of RWE Acceptance Today and in the Future
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03703-2&doi=10.1016/j.jval.2022.09.1498
First page :
Section Title :
Open access? :
No
Section Order :
11046